Insight

Thomas Flaig: Honored to be able to speak at the annual NCCN meeting on the impact of recent research findings on the treatment of advanced bladder cancer

Photo from Thomas Flaig/X

Apr 14, 2024, 06:07

Thomas Flaig: Honored to be able to speak at the annual NCCN meeting on the impact of recent research findings on the treatment of advanced bladder cancer

Thomas Flaig, Vice Chancellor for Research at University of Colorado Denver, shared on X/Twitter:

“Honored to be able to speak at the annual National Comprehensive Cancer Network meeting on the impact of recent research findings on the treatment of advanced bladder cancer – a busy time in the field with several updates to the NCCN bladder cancer guidelines.”

View additional information.
Source: Thomas Flaig/X

advanced bladder cancer Anschutz Medican Campus bladder cancer cancer National Comprehensive Cancer Network NCCN OncoDaily Oncology Thomas Flaig University of Colorado

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer